Literature DB >> 29393053

Inflammatory and Ischemic Post Liver Transplant Complications Mimic Malignancy on 18F-FDG PET/CT.

William Makis1, Anthony Ciarallo2, Stephan Probst3.   

Abstract

A 65-year-old male patient with a one year history of liver transplantation was referred for an 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) to rule out post transplant lymphoproliferative disease. Multiple foci of intense abnormal 18F-FDG uptake were seen in the transplanted liver which were concerning for malignancy. Explantation of the liver approximately 1 month following the PET/CT revealed multiple inflammatory and ischemic changes including large bile duct necrosis, acute cholangitis, bile duct obstruction changes and periportal fibrosis, with no evidence of malignancy. We present the 18F-FDG PET/CT image findings of this case.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography.; Liver transplant; artifact; complications; pitfall

Year:  2018        PMID: 29393053      PMCID: PMC5790973          DOI: 10.4274/mirt.03371

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther


  15 in total

1.  18F-FDG PET in detecting metastatic infectious disease.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Geert J A Wanten; Jos W M van der Meer; Frans H M Corstens; Bart-Jan Kullberg; Wim J G Oyen
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

2.  False-positive uptake of FDG in hepatic sarcoidosis.

Authors:  Andrew N Guglielmi; Benedict Y Kim; Bohdan Bybel; Nancy Slifkin
Journal:  Clin Nucl Med       Date:  2006-03       Impact factor: 7.794

3.  Evaluation of benign vs malignant hepatic lesions with positron emission tomography.

Authors:  D Delbeke; W H Martin; M P Sandler; W C Chapman; J K Wright; C W Pinson
Journal:  Arch Surg       Date:  1998-05

4.  A case of hepatic inflammatory pseudotumor identified by FDG-PET.

Authors:  Etsushi Kawamura; Daiki Habu; Hiroyuki Tsushima; Kenji Torii; Joji Kawabe; Masahiko Ohsawa; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2006-05       Impact factor: 2.668

5.  Detection of liver metastases from pancreatic cancer using FDG PET.

Authors:  A Fröhlich; C G Diederichs; L Staib; J Vogel; H G Beger; S N Reske
Journal:  J Nucl Med       Date:  1999-02       Impact factor: 10.057

6.  Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors.

Authors:  Theodore H Welling; David G Heidt; Michael J Englesbe; John C Magee; Randall S Sung; Darrell A Campbell; Jeffrey D Punch; Shawn J Pelletier
Journal:  Liver Transpl       Date:  2008-01       Impact factor: 5.799

7.  FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation.

Authors:  Bharat Mocherla; Jongho Kim; Sasan Roayaie; Suzanne Kim; Josef Machac; Lale Kostakoglu
Journal:  Clin Nucl Med       Date:  2007-12       Impact factor: 7.794

8.  (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

Authors:  Seung Duk Lee; Seong Hoon Kim; Young-Kyu Kim; Chulhan Kim; Seok-Ki Kim; Sung-Sik Han; Sang-Jae Park
Journal:  Transpl Int       Date:  2012-10-25       Impact factor: 3.782

9.  A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET.

Authors:  Etsushi Kawamura; Daiki Habu; Shigeaki Higashiyama; Hiroyuki Tsushima; Yoshihiro Shimonishi; Yuji Nakayama; Masaru Enomoto; Joji Kawabe; Akihiro Tamori; Norifumi Kawada; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2007-06-25       Impact factor: 2.668

10.  Biliary tract complications following liver transplantation.

Authors:  W Patkowski; P Nyckowski; K Zieniewicz; J Pawlak; B Michalowicz; M Kotulski; P Smoter; M Grodzicki; A Skwarek; J Ziolkowski; U Oldakowska-Jedynak; M Niewczas; L Paczek; M Krawczyk
Journal:  Transplant Proc       Date:  2003-09       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.